Stocks and Investing Stocks and Investing
Tue, April 2, 2024
Mon, April 1, 2024

Li Watsek Reiterated (ASND) at Buy and Held Target at $173 on, Apr 1st, 2024


Published on 2024-10-28 10:01:46 - WOPRAI, Li Watsek
  Print publication without navigation


Li Watsek of Cantor Fitzgerald, Reiterated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $173 on, Apr 1st, 2024.

Li has made no other calls on ASND in the last 4 months.



There are 4 other peers that have a rating on ASND. Out of the 4 peers that are also analyzing ASND, 0 agree with Li's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Li


  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $260 on, Friday, March 15th, 2024
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $225 on, Thursday, February 8th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $182 on, Thursday, February 8th, 2024
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $150 on, Wednesday, December 20th, 2023
Contributing Sources